Mendoza PN

Language: Spanish
References: 10
Page: 213-214
PDF size: 45.52 Kb.

Text Extraction

No abstract

REFERENCES

1. Goldstein EJ, Citron DM, Richwald GA. Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin and oxacilin against Pasteurella multocida. Antimicrob, Agents. Chemother, 1988; 32: 213-215.

2. Goodman and Gilman’s. The pharmacological basis of therapeutics. 11th edition. McGraw-Hill 2006 USA.

3. Haas DW, Stratton CW, Griffin JP, Weeks L, Alls SC. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone. Against Streptococcus pneumoniae. Clin Infect Dis 1995; 20: 671-676.

4. Hamilton-Miller JM, Brumfitt W. Activity of ceftazidime (GR 20263) against nosocomially import pathologens. Antimicrob. Agents Chemother 1981; 19: 1067-1069.

5. Herrera CJ. Manual de farmacia clínica y atención farmacéutica. Elsevier España 2003.

6. John CC. Treatment failure with use of a third generation cephalosporin for penicillin-resistant pneumococcal meningitis: Case report and review. Clin Infect Dis 1994; 18: 188-193.

7. Neu HC, Aswapokee N, Aswapokee P, Fu, P. HR756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1979; 15: 273-281.

8. Neu HC, Turck M, Phillips I. Ceftizonxiome a broad-spectrum B lactamasa stable cephalosporin. J Antimicrob Chemother 1982; 10(suppl. C): 1-355.

9. Phillips I, Wise R, Leigh DA. Cefotetan: A new cephamycin. J Antimicrob Chemother 1983; 11(suppl.): 1-239.

10. Schaad UB, Suter S, Gianella-Borradori A et al. A comparison of ceftriaxone an cefuroxime for the treatment of bacterial meningitis in children. New Engl J Med 1990; 322: 141-147.